DISPERSYN GERRIT (Chief Development Officer) purchased 2.9% of their position (2.50K shares) of PHIO PHARMACEUTICALS CORP. on the open market
Open‑market purchase worth $7.6K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/3/2021ACC: 0001209191-21-017569
Officer· Chief Development Officer
Since Aug 2018
+70.95K
Net shares
Net buyer
$7.6K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
70.95K acquired
Non-Derivative Transactions2
Common stock, $0.0001 par value
Direct
Shares
+68.45K
Price / share
—
Trade value
—
% of position
417.9%
3/1/2021
16.38K→84.83K
Common stock, $0.0001 par value
Direct
Shares
+2.50K
Price / share
$3.03
Trade value
$7.57K
% of position
2.9%
3/3/2021
84.83K→87.33K
Total
Net shares
+70.95K
Net value
$7.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value Direct | 3/1/2021 | A · Award | +68.45K | — | — | 417.9% | 16.38K | 84.83K |
| Common stock, $0.0001 par value Direct | 3/3/2021 | P · Purchase | +2.50K | $3.03 | $7.57K | 2.9% | 84.83K | 87.33K |
| Total | +70.95K | $7.57K | ||||||
Derivative Transactions0
No derivative transactions reported